MCM
GILD icon

Maryland Capital Management’s Gilead Sciences GILD Stock Holding History

Maryland Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,553
Closed -$231K – 184
2019
Q1 		$231K Buy
+3,553
New +$236K 0.03% 164
2016
Q1 		– Sell
-2,000
Closed -$202K – 163
2015
Q4 		$202K Buy
+2,000
New +$208K 0.03% 150
2015
Q3 		– Sell
-1,900
Closed -$222K – 168
2015
Q2 		$222K Buy
+1,900
New +$208K 0.03% 162
2014
Q4 		– Sell
-1,950
Closed -$208K – 186
2014
Q3 		$208K Buy
+1,950
New +$191K 0.04% 179

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Maryland Capital Management's GILD Position: Q2 2019 in Review

Maryland Capital Management sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 3,553 shares — an estimated $231K sold.

Maryland Capital Management first reported a position in GILD in Q3 2014 and held it in 4 quarters. The position peaked at $231K in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Maryland Capital Management reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Maryland Capital Management sold 3,553 Gilead Sciences shares in Q2 2019, an estimated $231K.
  • Maryland Capital Management first reported a position in Gilead Sciences in Q3 2014 and held it in 4 quarters.
  • Maryland Capital Management's Gilead Sciences position peaked at $231K in Q1 2019.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Maryland Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.